“A new test gauging levels of key proteins in the blood was far more accurate than doctor assessments in spotting Alzheimer’s disease in people with early-stage illness.
“The test, called APS2 (the amyloid probability score 2), was 91% accurate in diagnosing Alzheimer’s in people with mild cognitive decline or early dementia, compared to the 61% success rate of primary care doctors who examined the same patients.”
Read more at Health Day
